MED13L and arthritic joint disease: To summarize, we propose that the amino acid substitutions caused by rs13478486 (E814D) and rs33215085 (V1222I) variations in Med13L, do not affect arthritis development in the CIA model and lymphocyte development and function in general, and are less likely to be associated with immune-related diseases.